T1	Pharmacological_substance 67 76	sorafenib
N1000 	Reference T1 MeSH:C471405	sorafenib
T2	Pharmacological_substance 79 88	Sorafenib
N1001 	Reference T2 MeSH:C471405	Sorafenib
T4	Disorder 162 186	hepatocellular carcinoma
N1 	Reference T4 UMLS:C2239176	hepatocellular carcinoma
T5	Disorder 200 221	renal cell carcinomas
N2 	Reference T5 UMLS:C0007134	renal cell carcinomas
T6	Pharmacological_substance 564 573	sorafenib
N1002 	Reference T6 MeSH:C471405	sorafenib
T3	Disorder 10 50	Localized dyskeratotic plaque with milia
T8	Pharmacological_substance 92 122	multitargeted kinase inhibitor
T10	Disorder 316 341	dermatologic side effects
T12	Disorder 396 419	hand-foot skin reaction
N3 	Reference T12 UMLS:C1579527	hand-foot skin reaction
T13	Disorder 456 493	atypical localized cutaneous eruption
N4 	Reference T13 UMLS:C0015230	atypical localized cutaneous eruption
T15	Speculation_cue 342 350	reported
T16	Coreferring_mention 260 263	its
